SciRhom GmbH is a German biotechnology company...
Continue Reading-
Attgeno announces positive results from Supernitro Phase II study
Attgeno announces positive results from Supernitro Phase II study — Hadean Ventures Home Portfolio Team…
Continue Reading -
Oncoinvent Receives FDA Fast Track Designation for Radspherin®
Oncoinvent Receives FDA Fast Track Designation for Radspherin® — Hadean Ventures Home Portfolio Team Impact…
Continue Reading -
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease — Hadean Ventures…
Continue Reading -
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa...
Continue Reading -
Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial
Alex Therapeutics Reports Positive Results...
Continue Reading -
Hadean Ventures announces oversubscribed final close of Hadean Capital II
Hadean Ventures announces oversubscribed final close of Hadean Capital II
Continue Reading -
Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer
Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer — Hadean Ventures Home Portfolio Team Impact…
Continue Reading -
Complement Therapeutics Enrols First US Participant
Complement Therapeutics Enrols First US Participant — Hadean Ventures Home Portfolio Team Impact Investors News…
Continue Reading -
Abliva Achieves Important Milestone in the Ongoing FALCON Study
Abliva Achieves Important Milestone in the Ongoing FALCON Study — Hadean Ventures Home Portfolio Team…
Continue Reading